Norms notified to skip test licences for R&D to boost pharma research
Published on: Jan. 29, 2026, 7:40 a.m. | Source: The New Indian Express
The amendment is in line with the directions of PM Narendra Modi to reduce regulatory burden and promote ease of doing business, the ministry said in a statemen
